Tremfya Fertigpen

Active Ingredient:: Guselkumab Injection Pen
Brand:: Tremfya
Origin:: China

Buy Tremfya Fertigpen Guselkumab Injection Pen

Tremfya Fertigpen (guselkumab 100mg/ml) is a pre-filled injection pen for managing immune-mediated conditions. Store between 2–8°C and use as directed by a healthcare provider. This biologic therapy targets specific pathways in plaque psoriasis and psoriatic arthritis.

Strength

100mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Janssen - Cilag AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Tremfya Fertigpen (guselkumab 100mg/ml) is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also prescribed for active psoriatic arthritis, helping reduce joint damage and skin symptoms. Patients often ask, 'what is guselkumab injection used for' to address these chronic inflammatory conditions.

Side Effects

After use, many patients notice improvements in skin plaques and joint discomfort over time. The injection works gradually to modulate immune responses, which may lead to reduced redness and scaling. Individual responses vary, and consistent use is important for best results.

Precautions & Warnings

Keep the Tremfya Fertigpen refrigerated between 2–8°C and protect from light. Do not freeze or shake vigorously. Before using, inspect the pen for particles or discoloration. Always follow the handling instructions provided with the device to maintain sterility and effectiveness.

Avoid Interactions

Concurrent use with live vaccines is not recommended while on guselkumab therapy. Inform your healthcare provider about all medications, including over-the-counter drugs and supplements. Certain immunosuppressants may increase infection risk when combined with this treatment.

References

Frequently Asked Questions

Store the pen refrigerated between 2–8°C and avoid freezing. Keep it in the original packaging to protect from light until ready to use.

Consult your healthcare provider before using if you have an active infection. Guselkumab may lower your ability to fight infections.

Contact your healthcare provider for guidance if you miss a scheduled dose. Do not take a double dose to make up for a missed injection.

The safety of guselkumab during pregnancy has not been established. Discuss risks and benefits with your doctor if you are pregnant or planning pregnancy.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.